World-renowned physician, Dr. Michael Roizen, MD, continues to update your understanding of the meaning of health by providing an in-depth review of the most impactful health headlines. He discusses the health news that matters most to you.
Dr. Roizen is later joined by Robert J. Evans, MD, and in the second hour, Celebrity Chef, Amanda Freitag.
In the first hour, Dr. Evans, associate professor of urology at Wake Forest Baptist Health, explains the symptoms, causes and therapies of painful bladder syndrome that may offer relief.
Bonus!
Real Age Tip
Four Things to Know About the Trans Fat Ban
Hour 1: YOU The Owner's Manual Radio 10.3.15
Featuring:
Robert J. Evans III, MD, FACS is an associate professor in the Department of Urology at Wake Forest School of Medicine.
He directs the clinic operations of the department at Wake Forest. Dr. Evans specializes in pelvic pain syndrome, including painful bladder syndrome/interstitial cystitis. Dr. Evans holds board certification from, and is a diplomat of, the American Board of Urology and the National Board of Examiners.
He is a member of the board of directors of the Interstitial Cystitis Association and serves on the association’s Medical Advisory Board. Included in Dr. Evans’ experience as a researcher, is his role as the director of a 23-center study that showed preliminary efficacy of a monoclonal antibody for treating pain associated with interstitial cystitis. He will begin enrolling patients in three new interstitial cystitis trials this year.
Dr. Evans serves as an invited lecturer at medical and educational venues nationwide. His articles have been published in a variety of peer reviewed journals.
Robert J. Evans III, MD, FACS
Robert J. Evans III, MD, FACS is an associate professor in the Department of Urology at Wake Forest School of Medicine. He directs the clinic operations of the department at Wake Forest. Dr. Evans specializes in pelvic pain syndrome, including painful bladder syndrome/interstitial cystitis. Dr. Evans holds board certification from, and is a diplomat of, the American Board of Urology and the National Board of Examiners.
He is a member of the board of directors of the Interstitial Cystitis Association and serves on the association’s Medical Advisory Board. Included in Dr. Evans’ experience as a researcher, is his role as the director of a 23-center study that showed preliminary efficacy of a monoclonal antibody for treating pain associated with interstitial cystitis. He will begin enrolling patients in three new interstitial cystitis trials this year.
Dr. Evans serves as an invited lecturer at medical and educational venues nationwide. His articles have been published in a variety of peer reviewed journals.